Molecular Therapy

{{distinguish|Molecular medicine|Auger therapy}}

{{Infobox journal

| title = Molecular Therapy

| image =

| caption =

| former_name =

| abbreviation = Mol. Ther.

| discipline = Genetic diseases

| peer-reviewed =

| language =

| editor = Joseph Glorioso

| publisher = Cell Press

| country =

| history = 2000–present

| frequency = Monthly

| openaccess =

| license =

| impact = 12.1

| impact-year = 2023

| ISSNlabel =

| ISSN = 1525-0016

| eISSN = 1525-0024

| CODEN =

| JSTOR =

| LCCN =

| OCLC = 41354718

| website = https://www.journals.elsevier.com/molecular-therapy

| link1 =

| link1-name =

| link2 =

| link2-name =

}}

Molecular Therapy is a scientific journal, published by Cell Press, that aims to develop and explore "molecular and cellular therapeutics to correct genetic and acquired diseases".{{Cite web|url=https://www.journals.elsevier.com/molecular-therapy|title=Molecular Therapy - Journal - Elsevier}}

The founder of the journal and its Editor-in-Chief in the first five years was Inder Verma.{{Cite web|url=https://www.salk.edu/news-release/salk-scientist-inder-verma-to-receive-2009-outstanding-achievement-award-from-american-society-of-gene-therapy/|title = Salk Scientist Inder Verma to Receive 2009 Outstanding Achievement Award from American Society of Gene Therapy}}